Cargando…

Neoadjuvant Pseudomonas aeruginosa mannose-sensitive hemagglutinin (PA-MSHA) and chemotherapy versus placebo plus chemotherapy in patients with HER2-negative breast cancer: a randomized, controlled, double-blind trial

BACKGROUND: According to preclinical experiments, Pseudomonas aeruginosa mannose-sensitive hemagglutinin (PA-MSHA) exerts antiproliferative effects against breast cancer cells. It has been approved by the State Food and Drug Administration in China for complementary cancer treatment, and its safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Yue, Zuo, Hua, Zhou, Ying, Yu, Ke-Da, Liu, Guang-Yu, Di, Gen-Hong, Wu, Jiong, Liu, Zhe-Bin, Shao, Zhi-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113104/
https://www.ncbi.nlm.nih.gov/pubmed/37082658
http://dx.doi.org/10.21037/atm-22-4093